We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Malaria Parasitaemia Correlated with Monocyte to Lymphocyte Ratio

By LabMedica International staff writers
Posted on 28 Nov 2018
Print article
Image: The ABX Pentra 60 C+ automated hematological analyzer (Photo courtesy of Horiba).
Image: The ABX Pentra 60 C+ automated hematological analyzer (Photo courtesy of Horiba).
In spite of a declining trend in the number of cases and deaths over the last few years, malaria still causes significant mortality and morbidity and the bulk of the burden is observed in children under five years of age.

During the course of malaria infection, parasites and red blood cells come under oxidative stress and there is host immune response in an attempt to protect the red blood cells. The frequency of monocytes and lymphocytes in peripheral blood might, therefore, be expected to reflect the state of an individual’s immune response to the infection.

Medical laboratory scientists at the University of Ghana (Accra, Ghana) conducted a case control study between the years 2014 and 2017, that included children, both male and female up to five years and four months old attending the selected hospitals and presenting with clinical malaria as cases and apparently healthy pre-school and school children undergoing health screening as the controls. Venous blood sample were taken from participants by phlebotomy into anticoagulant tubes. Thick and thin blood films were made and stained with Giemsa and examined for malaria parasites.

For hematological analysis, whole blood specimens were analyzed for full blood count using ABX Pentra 60 C+ automated hematological analyzer and the result used to estimate the monocytes and lymphocytes ratio of each participant. Also the thin smears were examined to confirm the morphology of the cells. The absolute count of the monocytes and lymphocytes level of each sample was entered into a calculator and the ratio was estimated by dividing the monocytes by the lymphocyte counts. The other ratios were calculated using the same formula.

The study comprised of 1,629 (males = 55%) children presenting with clinical malaria as cases and 445 (males = 57.7%) apparently healthy children as controls. Blood samples from the malaria patients showed positive blood smear for malaria parasites, while no parasites were found in the healthy control subjects. There was a significant difference between lymphocytes of the case group and that of the controls and there was also significant difference between the monocytes to lymphocytes ratio of the cases and controls. Significant difference in neutrophil to lymphocyte ratios between the two study groups was also observed.

The authors concluded that the monocyte to lymphocyte ratio obtained correlated positively with the presence of malaria as well as the level of parasitaemia. The outcome of this work implies that monocyte to lymphocyte ratio can be used to predict the level of parasitaemia and together with other factors, the development of severe malaria. The study was published on November 12, 2018, in the Malaria Journal.

Related Links:
University of Ghana

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.